Global Cervical Cancer Diagnostics Market Size to Reach USD 12.69 Billion in 2030 - Government awareness programs on cervical cancer and mass procurement of testing kits for women are expected to drive market revenue growth says Reports and Data
The global cervical cancer diagnostics market size is expected to reach USD 12.69 Billion in 2030 and register a revenue CAGR of 5.8% over the forecast period, according to latest report by Reports and Data. Market revenue growth of cervical cancer diagnostics can be attributed to factors such as growing geriatric population and great accuracy of pap smear test in detecting cervical cancer.
Cervical cancer is a type of cancer that begins in the cervix due to abnormal growth of cells. Symptoms of this cancer may include abnormal vaginal bleeding, pelvic pain, or pain during sexual intercourse. Bleeding after sex may not be serious, but it may indicate presence of cervical cancer. Human papillomavirus infection causes more than 90% cases of cervical cancer, and hence, it is important to detect the virus at the early stage.
Confirmation of diagnosis of cervical cancer requires a biopsy of the cervix, which is often done through colposcopy, which facilitates a magnified visual inspection of the cervix aided by a dilute acetic acid solution to highlight abnormal cells on surface of the cervix, with visual contrast provided by staining the normal tissues. However, continuous examination and overdiagnosis are some serious concerns, and therefore, private healthcare and pharmaceutical firms are focusing on developing ways of identifying spread of the disease with minimal scans.
The cost of a single scan is significantly high, and hence frequent prescription of scans by doctors can cause financial burden on patients while treating diseases including cervical cancer. Therefore, governments of various countries are focusing on developing more research laboratories to develop easy, cost-effective, and efficacious diagnostic techniques for patients. In developing regions, companies are focusing on expanding their customer base, as women in these regions are not well educated or aware of this disease. Hence, awareness programs and cost-effective diagnostic techniques can help women to prevent cervical cancer. Furthermore, use of AI in diagnosis and treatment of cancer can help in eliminating various issues, such as errors in cancer diagnosis, which is expected to drive market revenue growth.
Request a Sample Report – https://www.reportsanddata.com/sample-enquiry-form/1438
Some Key Highlights from the Report
- Cervical cancer is a severe cancer with high a mortality rate, and therefore, early diagnosis is important to reduce mortality rates. Several techniques have been developed for detecting this disease, and one such technique involves screening with tiny beads made of biological material, which form a diamond shape when they contact HPV. Those shapes can be detected with powerful microscopes. Similar technologies with state-of-the-art innovations are expected to drive market revenue growth.
- Among test type segments, pap smear tests segment accounted for largest revenue share in 2021 and is expected to register a faster revenue CAGR during the forecast period, due to increasing adoption of pap smear test for diagnosing cervical cancer, as it is extremely effective and precise in detecting cancer cells before cancer symptoms are observed in patients. Furthermore, it traces these cancer cells before the disease spreads to other regions of the body. The pap smear test is the most common type of cervical cancer diagnostic test, which involves collection of cells from near the cervix. Introduction of artificial intelligence and machine learning software for cancer diagnosis is expected to drive segment revenue growth.
- Among end-use segments, hospitals and clinics segment accounted for largest revenue share in 2021, due to initiatives taken by governments to develop new specialized cancer hospitals for patients. Private healthcare companies are also focusing on investing in establishing clinics and hospitals for patients in developing regions, while various R&D facilities in hospitals are focusing on developing affordable testing kits and better imaging scans at cost-effective pricing. Laboratories are also an integral part of hospitals for giving accurate test results in a time-bound manner.
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1438
- In May 2021, Becton, Dickinson and Company announced industry-first CE Marked Assay for HPV screening from at-home self-collected vagina samples. It allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD on clarity HPV assay, on either the BD Viper LT or the BD COR System. The goal is to make cervical cancer screening a simple process and increase its accessibility for women, which in turn, can help to increase their confidence in such tests.
- Companies profiled in the global market report include Abbott Laboratories Ltd., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Guided Therapeutics Inc., Hologic Inc., Qiagen N.V., Quest Diagnostics Inc., CooperSurgical Inc., and Arbor Vita Corporation.
To identify the key trends in the industry, research study at https://www.reportsanddata.com/report-detail/cervical-cancer-diagnostic-market
For this report, Reports and Data has segmented the global cervical cancer diagnostics market based on test type, end-use, therapy, and region:
- Test Type Outlook (Revenue, USD Billion; 2019–2030)
- Pap Smear Tests
- Colposcopy
- HPV Testing
- Biopsy and Endocervical curettage
- Others
- End-use Outlook (Revenue, USD Billion; 2019–2030)
- Hospitals and Clinics
- Laboratories
- Diagnosing Centers
- Others
- Therapy Outlook (Revenue, USD Billion; 2019–2030)
- Surgery
- Radiation Therapy
- Chemotherapy
- Targeted Therapy
Buy Premium Research Report @ https://www.reportsanddata.com/report-pricing/1438
- Regional Outlook (Revenue, USD Billion; 2019–2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
- North America
Explore Trending Research Reports by Reports and Data:
Autoinjectors Market Analysis By Type (Disposable Autoinjectors and Reusable Auto-injectors), By Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), By End User (Homecare Settings and Hospitals & Clinics), And By Region Forecast To 2028 | Download Sample Report
Tissue Contact Probe Ablators Market Analysis By Product Type (Unipolar, Multipole), By Application (Surgery, Pain Management, Others), And By Region Forecast to 2028 | Download Sample Report
Suture Market by Product (Absorbable, Non-Absorbable), By Filament Type (Monovalent, Multivalent), Application (Cardiac, Gynae, Ophthalmic, Orthopedic, Neurological), End User (Hospital, Ambulatory Surgical Centers) And Region, Forecast 2018 To 2028 | Download Sample Report
Stethoscope Market By Product, By Design (Single Head, Double Head, Triple Head), By Usability (Reusable, Disposable), By Tube Type (Single Tube, Double Tube), By Material (Stainless Steel, Aluminum, Zinc, Silicone, Wooden), By End-use And Region, Forecast 2020 To 2028 | Download Sample Report
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-cervical-cancer-diagnostic-market